Skip links

Committed to Curing Cancer

We behold the belief of a cancer-free life with advanced gene and immunotherapy technology.

Committed to Curing Cancer
Researcher Microscope Biotechnologist

CAR T-Cells Technology

US FDA has approved CAR T-cell therapy for B-cell acute lymphoblastic leukaemia, B-cell non-Hodgkin lymphoma and multiple myeloma.

CAR T-cells therapy are genetically modified T cells that possesses a wider and precise attack power to locate and eradicate cancer cells in the patient’s body.

Our Key Opinion Leader

“The emergence of CAR T-cell therapy is phenomenonal. It’s a breakthrough for cancer treatment after decades of research and clinical studies.”

Academician Emeritus Professor Dr. Cheong Soon Keng
Consultant Haematologist

Contact us for more information

    For patients outside of Malaysia, kindly provide your contact details with international calling code/ dialling prefix.